Substitution of the SEMA3A basic domain with the VEGF(165) heparin-binding domain enhances anti-angiogenic potency in ovo.

Valiulytė-Simaitė I, Šlekienė L, Balnytė I, Daukšaitė V, Tacionis S, Paškevičiūtė G, Mašalaitė K, Kazlauskas A

DOI: 10.1186/s40659-026-00684-z
Published: 2026 Mar 16
Container: Biological research
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s40659-026-00684-z,
  title = {Substitution of the SEMA3A basic domain with the VEGF(165) heparin-binding domain enhances anti-angiogenic potency in ovo.},
  author = {Valiulytė-Simaitė I and Šlekienė L and Balnytė I and Daukšaitė V and Tacionis S and Paškevičiūtė G and Mašalaitė K and Kazlauskas A},
  year = {2026},
  journal = {Biological research},
  doi = {10.1186/s40659-026-00684-z},
  url = {https://doi.org/10.1186/s40659-026-00684-z}
}

RIS

TY  - JOUR
TI  - Substitution of the SEMA3A basic domain with the VEGF(165) heparin-binding domain enhances anti-angiogenic potency in ovo.
AU  - Valiulytė-Simaitė I
AU  - Šlekienė L
AU  - Balnytė I
AU  - Daukšaitė V
AU  - Tacionis S
AU  - Paškevičiūtė G
AU  - Mašalaitė K
AU  - Kazlauskas A
PY  - 2026
JO  - Biological research
DO  - 10.1186/s40659-026-00684-z
UR  - https://doi.org/10.1186/s40659-026-00684-z
ER  -

APA

I, V., L, Š., I, B., V, D., S, T., G, P., K, M., & A, K. (2026). Substitution of the SEMA3A basic domain with the VEGF(165) heparin-binding domain enhances anti-angiogenic potency in ovo.. Biological research. https://doi.org/10.1186/s40659-026-00684-z

Source records

pubmed · retrieved 2026-09-26T23:59:06.501Z